Anika Therapeutics (ANIK) Construction in Progress (2011 - 2016)
Anika Therapeutics' (ANIK) quarterly Construction in Progress came in at $22.7 million in Q4 2016, up 101.3% year-on-year from $11.3 million in Q1 2016, and up 101.3% on a QoQ basis from $11.3 million in Q4 2015.
Anika Therapeutics (ANIK) Construction in Progress (2011 - 2016) Analysis & Trends
Anika Therapeutics (ANIK) has 6 years of Construction in Progress data on file, last reported at $22.7 million in Q4 2016.
- On a quarterly basis, Construction in Progress rose 101.3% year-over-year to $22.7 million in Q4 2016; TTM through Dec 2016 was $22.7 million, a 101.3% increase from a year earlier, with the FY2016 full-year figure at $22.7 million, up 101.3% from the prior year.
- Construction in Progress for Q4 2016 stood at $22.7 million, up from $11.3 million in the prior quarter.
- Over the last five years, Construction in Progress for ANIK reached as high as $22.7 million in Q4 2016 and fell as low as $42270.0 in Q4 2012.
- Historically, Construction in Progress has averaged $6.9 million across 5 years, with a median of $559000.0 in 2014.
- Across the five-year window, Construction in Progress slumped 99.84% in 2012 and surged 1916.82% in 2015, its largest moves.
- Year by year, Construction in Progress stood at $42270.0 in 2012, then soared by 272.11% to $157292.0 in 2013, then surged by 255.39% to $559000.0 in 2014, then jumped by 1916.82% to $11.3 million in 2015, then soared by 101.3% to $22.7 million in 2016.
- Per Business Quant data, the three most recent Construction in Progress figures were $22.7 million in Q4 2016, $11.3 million in Q4 2015, and $559000.0 in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Anika Therapeutics | 198.50 Mn | 131.71 Mn | 19.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 22.70 Mn |
| Dec 31, 2015 | 11.27 Mn |
| Dec 31, 2014 | 559,000.00 |
| Dec 31, 2013 | 157,292.00 |
| Dec 31, 2012 | 42,270.00 |
| Dec 31, 2011 | 27.16 Mn |